Rapid antiretroviral therapy initiation in low- and middle-income countries: A resource-based approach

Mark W Tenforde; A Sarah Walker; Diana M Gibb; Yukari C Manabe

doi:10.1371/journal.pmed.1002723

Rapid antiretroviral therapy initiation in low- and middle-income countries: A resource-based approach

PLoS Med. 2019 Jan 15;16(1):e1002723. doi: 10.1371/journal.pmed.1002723. eCollection 2019 Jan.

Authors

Mark W Tenforde^{1

2

3}, A Sarah Walker⁴, Diana M Gibb⁴, Yukari C Manabe^{5

6}

Affiliations

¹ Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America.
² Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington, United States of America.
³ Botswana-UPenn Partnership, Gaborone, Botswana.
⁴ Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom.
⁵ Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
⁶ Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.

Abstract

In an Essay, Mark Tenforde and colleagues advocate continued provision of baseline CD4 cell count testing in HIV care in low- and middle-income countries.

MeSH terms

AIDS-Related Opportunistic Infections / prevention & control
Anti-HIV Agents / therapeutic use*
CD4 Lymphocyte Count
Developing Countries
HIV Infections / diagnosis
HIV Infections / drug therapy*
Humans
Practice Guidelines as Topic
Time Factors

Substances

Anti-HIV Agents

Abstract

MeSH terms

Substances

Grants and funding